Metagenomi, Inc. Common Stock

Go to Metagenomi, Inc. Common Stock Website

$2.27

-0.03 (-1.30%)
Live
Previous Close

$2.3

Day Range

$2.21 - $2.3192

Previous Day Range

$2.1608 - $2.32

Market Cap

$84.1 million USD

Day Vol.

299941

Previous Day Vol.

325311

Currency

USD

Primary Exchange

None

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small ed...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Metagenomi presented data at the ASGCT Annual Meeting 2025, showcasing advancements in its gene editing technologies, including compact nucleases for extrahepatic gene editing and CAST for site-specific integration of large therapeutic genes.

Related tickers: MGX.

Read Full Article

Metagenomi, a precision genetic medicines company, announced upcoming scientific presentations and provided updates on its gene editing technology and pipeline. The company highlighted positive results from a nonhuman primate study for its hemophilia A treatment and advancements in its CRISPR-associated transposase (CAST) systems.

Related tickers: MGX.

Read Full Article
Trending Tickers

Please sign in to view